Description

EMPAGEN M 12.5/500MG: Detailed Information
EMPAGEN M 12.5/500MG is a combination medication that includes empagliflozin and metformin. This medication is specifically designed to manage type 2 diabetes by improving blood sugar control.
Empagliflozin works by helping the kidneys remove glucose from the bloodstream. This process effectively lowers blood sugar levels. Metformin, on the other hand, decreases glucose production in the liver and improves the body’s sensitivity to insulin. Together, these two mechanisms provide a comprehensive approach to managing blood sugar levels in individuals with type 2 diabetes.
Uses
EMPAGEN M 12.5/500MG is used to:
Improve blood sugar control in adults with type 2 diabetes.
Lower the risk of death from heart attack, stroke, or heart failure in adults with type 2 diabetes who also have heart disease¹².
Dosage and Administration
The dosage of EMPAGEN M 12.5/500MG should be determined by a healthcare provider based on the patient’s medical condition and response to treatment. It is typically taken twice daily with meals to reduce the risk of gastrointestinal side effects².
Side Effects
Common side effects of EMPAGEN M 12.5/500MG may include:
Low blood sugar
Indigestion, stomach pain, gas, nausea, vomiting, diarrhea
Bladder infection
Yeast infection in women (vaginal itching or discharge)
Headache, weakness
Runny or stuffy nose, sore throat¹²
More serious side effects should be reported to a healthcare provider immediately. These may include severe stomach pain, vomiting, tiredness, trouble breathing, or signs of a bladder infection¹.
Conclusion
EMPAGEN M 12.5/500MG is an effective combination medication for managing type 2 diabetes. By combining the benefits of empagliflozin and metformin, it helps control blood sugar levels and reduces the risk of cardiovascular events. Patients should follow their healthcare provider’s instructions and report any side effects to ensure the best possible outcomes.